Vilacto Bio offering natural alternatives to strong drugs in the Psoriasis and diabetics market
NEW YORK, April 09, 2019 (GLOBE NEWSWIRE) -- Denmark-based Vilacto Bio Inc. (OTC QB: VIBI) is happy to announce that the company has decided to introduce 2 new products and present them for the market later this summer/fall. The company will present one product for...
Vilacto Bio Canada Patent LACTOACTIVE® Granted
Vilacto Bio Canada Patent LACTOACTIVE® Granted Press Release | 03/15/2019 NEW YORK, March 15, 2019 (GLOBE NEWSWIRE) -- Denmark-based Vilacto Bio Inc. (OTC QB:VIBI) is happy to announce that the Canadian Intellectual Property Office (CIPO) has informed the Company that...
Vilacto Bio Secured Patent Applications for LACTOACTIVE®
Vilacto Bio Secured Patent Applications for LACTOACTIVE® NEW YORK, Nov. 30, 2018 (GLOBE NEWSWIRE) -- New York-based Vilacto Bio Inc. (OTC QB:VIBI) has secured the patent applications for LACTOACTIVE® covering rights in the US, Canada Europe and Hong Kong. The...
Vilacto Bio Announces Launch of Carmen Electra by Vilact®
Vilacto Bio Announces Launch of Carmen Electra by Vilact® Press Release | 10/01/2018 COPENHAGEN, Denmark, Oct. 01, 2018 (GLOBE NEWSWIRE) -- Vilacto Bio Inc. (OTC QB:VIBI) has launched its new skincare product, Carmen Electra by Vilact, based on the company’s...
Vilacto Bio Unveils Development Programs for LACTOACTIVE iTHER®
Vilacto Bio Unveils Development Programs for LACTOACTIVE iTHER® Press Release | 09/21/2018 COPENHAGEN, Denmark, Sept. 21, 2018 (GLOBE NEWSWIRE) -- Vilacto Bio Inc. (OTC QB:VIBI) has revealed the initial five areas of development for its new LACTOACTIVE iTHER®...
Vilacto Bio Introduces New LACTOACTIVE iTHER® Compound
Vilacto Bio Introduces New LACTOACTIVE iTHER® Compound Press Release | 09/10/2018 COPENHAGEN, Denmark, Sept. 10, 2018 (GLOBE NEWSWIRE) -- Vilacto Bio Inc. (OTC QB:VIBI) has launched its LACTOACTIVE iTHER® product. LACTOACTIVE iTHER® is a new LACTOACTIVE variant that...
Vilacto Bio Focuses Resources On Pharmaceutical Opportunities for LACTOACTIVE iTHER®
Vilacto Bio Focuses Resources On Pharmaceutical Opportunities for LACTOACTIVE iTHER® Press Release | 07/11/2018 COPENHAGEN, Denmark, July 11, 2018 (GLOBE NEWSWIRE) -- Vilacto Bio Inc. (OTCQB:VIBI) plans to focus on its new pharmaceutical product, LACTOACTIVE iTHER®,...
Vilacto Bio’s Vilact Skin Cream Wins Award at Las Vegas ECRM Skin, Bath, Cosmetics & Natural Beauty EPPS
Vilacto Bio’s Vilact Skin Cream Wins Award at Las Vegas ECRM Skin, Bath, Cosmetics & Natural Beauty EPPS COPENHAGEN, Denmark, June 14, 2018 (GLOBE NEWSWIRE) -- Vilacto Bio Inc.’s (OTCQB:VIBI) Vilact skin cream won the buyers choice award at the recent ECRM Skin, Bath,...
Vilacto Bio Inc. Upgrades Denmark Plant; Paves Way for New LACTOACTIVE iTHER® to Stimulate Local Antibody Production
Vilacto Bio Inc. Upgrades Denmark Plant; Paves Way for New LACTOACTIVE iTHER® to Stimulate Local Antibody ProductionPress Release | 05/23/2018 COPENHAGEN, Denmark, May 23, 2018 -- Vilacto Bio Inc. (OTC QB:VIBI) has completed a two-month upgrade to the Denmark...
Vilacto Bio Inc. Begins Development of the Vilacto Bio Skincare Knowledge Center
Vilacto Bio Inc. Begins Development of the Vilacto Bio Skincare Knowledge Center Jan 18, 2018 OTC Disclosure & News Service COPENHAGEN, Denmark, Jan. 18, 2018 (GLOBE NEWSWIRE) -- Vilacto Bio Inc. (OTCQB:VIBI), today announced that it has commenced development of the...